4574 — Taiko Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Taiko Pharmaceutical Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	9,906	6,098	3,505	5,484	4,532
Net Total Accounts Receivable
Net Total Receivables	4,387	4,056	1,798	1,985	2,428
Total Inventory
Total Other Current Assets
Total Current Assets	16,584	13,783	7,556	9,109	8,761
Net Property, Plant And Equipment	7,108	7,113	6,397	3,581	3,271
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	25,474	22,535	15,046	13,220	12,914
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4,794	4,320	2,793	3,046	2,855
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	6,100	9,728	7,002	6,481	4,950
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	19,374	12,807	8,044	6,739	7,964
Total Liabilities & Shareholders' Equity	25,474	22,535	15,046	13,220	12,914
Total Common Shares Outstanding